Currently, the state-of-the-art anaphylaxis treatment consists of fluid administration, vasopressors, supplemental oxygen, histamine 1 receptor (H1R) antagonists, and glucocorticoids [6, 7]. The gene discussed is HRH1; the disease is anaphylaxis.